NL-OMON34836尚未招募不适用
rine prothrombin fragments (F1+2) as a diagnostic tool for arterial and venous thrombosis - The UPF study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Males and females, aged 18 years and older with an objectively confirmed venous thrombo-embolism, either DVT or PE (by means of ultrasonography, computerized tomography or ventilation perfusion scanning) and an objectively confirmed diagnosis of
- •myocardial infarction (by means of elevated cardiac enzymes or abnormal elecocardiogram.
排除标准
- •Since this is a pilot study, there are no exclusion criteria.
研究者
相似试验
Unknown
不适用
Value of Prothrombin Fragment F1+2 in the Diagnosis of Pulmonary Embolism in Patients With Chronic Obstructive Pulmonary Disease (COPD) ExacerbationChronic Obstructive Pulmonary DiseasePulmonary EmbolismNCT01626521Hillel Yaffe Medical Center20
招募中
不适用
Validation of a new fibrinolysis assay for thrombelastometry on the ROTEM® deviceSepsis (with/without DIC), Liver impairment (Child-Pugh A/B/C), Patientgroups in which an altered hemostatic balance can be expected, like patients treated for hematological malignancies who have severe thrombocytopeniaNL-OMON21605MUMC+200
尚未招募
Unknown
Evaluating the diagnostic types of thrombotic microangiopathy (TMA) disorder to create a TMA registry in our populatioCTRI/2023/06/054550MAHE
尚未招募
不适用
Prehospital detection of hyperfibrinolysis in traumatized patients - a feasibility studyDRKS00021244Medizinische Hochschule Hannover Unfallchirurgie30
Unknown
不适用
Prognostic Value of Prothrombin Fragments 1+2 for Pulmonary Embolism IncidencePulmonary Disease, Chronic ObstructiveDisease ExacerbationProthrombin FragmentsPulmonary EmbolismNCT01078792Hillel Yaffe Medical Center